EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021

Chengjun Hu, Weifeng Chen, Ping Zhang, Tongping Shen iD, Maozhong Xu

PLOS One · 2025

DOI: 10.1371/journal.pone.0325937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Chengjun Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, Jiangsu 214400, China. Hauptthemen laut MEDLINE: Leukemia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Anhui Province School Nature Research Key Project, Anhui Province Teaching Research Program, Wuxi Municipal Health Commission Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Leukemia is a prevalent form of cancer that encompasses four primary subtypes, posing significant health risks. Gaining insights into the global epidemiology of leukemia and its subtypes is crucial for effective resource allocation, clinical guidance, and scientific inquiry.

Methods

From 1990 to 2021, we analyzed age-standardized rates (ASR) trends across 204 countries and territories, utilizing the estimated annual percentage change (EAPC).

Results

In 2021, there were approximately 460,000 leukemia cases, 320,000 deaths, and 10.98 million disability-adjusted life years (DALYs). Globally, age-standardized incidence rates (ASIR), mortality rates (ASMR), and DALY rates are on the decline, while age-standardized prevalence rates (ASPR) are rising in high social demographic index (SDI) regions. Men experience a higher leukemia burden compared to women. By subtype, acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL) predominantly impact older individuals, while acute lymphoblastic leukemia (ALL) primarily affects children. Notably, leukemia ASIR and ASDR reductions are observed in countries with high human development index (HDI).

Conclusion

Although there has been a marked decrease in global leukemia incidence, mortality, and DALYs over the past 31 years, the rise in new cases due to population growth suggests an increasing overall disease burden by 2050. Furthermore, the impact of leukemia varies significantly by region and country, highlighting the urgent need for innovative and personalized prevention and treatment approaches to mitigate this global health issue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeukemiaHumansFemaleMaleGlobal HealthIncidenceDisability-Adjusted Life YearsChildPrevalenceMiddle AgedAdultAdolescentAgedGlobal Burden of DiseaseChild, PreschoolInfant

Autor:innen und Institutionen

  • Department of Hematology, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, Jiangsu 214400, China.
  • School of Information Engineering, Anhui University of Chinese Medicine, Hefei, Anhui 230012, China.

ORCID-Profile: Tongping Shen

Förderung

  • the Anhui Province School Nature Research Key Project
  • Anhui Province Teaching Research Program
  • Wuxi Municipal Health Commission Project

Zitieren

APA

Hu, C., Chen, W., Zhang, P., Shen, T., & Xu, M. (2025). Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021. PLOS One. https://doi.org/10.1371/journal.pone.0325937

Vancouver

Hu C, Chen W, Zhang P, Shen T, Xu M. Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021. PLOS One. 2025. doi:10.1371/journal.pone.0325937

BibTeX
@article{Hu2025,
  author = {Hu, Chengjun and Chen, Weifeng and Zhang, Ping and Shen, Tongping and Xu, Maozhong},
  title = {Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325937}
}
Kostenlos starten →